Corcept Therapeutics Incorporated shares owned by Ingalls & Snyder
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ingalls & Snyder
from 13F filings
Historical chart of Ingalls & Snyder investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Corcept Therapeutics Incorporated by Ingalls & Snyder
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $383M | 8.3M | 46.26 |
2024-06-30 | $268M | 8.2M | 32.50 |
2024-03-31 | $210M | 8.3M | 25.33 |
2023-12-31 | $271M | 8.4M | 32.48 |
2023-09-30 | $227M | 8.3M | 27.25 |
2023-06-30 | $186M | 8.4M | 22.25 |
2023-03-31 | $181M | 8.4M | 21.66 |
2022-12-31 | $139M | 6.8M | 20.31 |
2022-09-30 | $178M | 7.0M | 25.64 |
2022-06-30 | $166M | 7.0M | 23.78 |
2022-03-31 | $156M | 6.9M | 22.52 |
2021-12-31 | $133M | 6.7M | 19.80 |
2021-09-30 | $139M | 7.1M | 19.68 |
2021-06-30 | $156M | 7.1M | 22.00 |
2021-03-31 | $165M | 6.9M | 23.79 |
2020-12-31 | $191M | 7.3M | 26.16 |
2020-09-30 | $130M | 7.5M | 17.41 |
2020-06-30 | $128M | 7.6M | 16.82 |
2020-03-31 | $95M | 8.0M | 11.89 |
2019-12-31 | $97M | 8.0M | 12.10 |
2019-09-30 | $123M | 8.7M | 14.14 |
2019-06-30 | $95M | 8.5M | 11.15 |
2019-03-31 | $98M | 8.4M | 11.74 |
2018-12-31 | $112M | 8.4M | 13.35 |
2018-09-30 | $118M | 8.4M | 14.00 |
2018-06-30 | $115M | 7.3M | 15.72 |
2018-03-31 | $112M | 6.8M | 16.45 |
2017-12-31 | $125M | 6.9M | 18.06 |
2017-09-30 | $133M | 6.9M | 19.30 |
2017-06-30 | $86M | 7.3M | 11.80 |
2017-03-31 | $86M | 7.8M | 10.96 |
2016-12-31 | $59M | 8.2M | 7.26 |
2016-09-30 | $56M | 8.6M | 6.50 |
2016-06-30 | $50M | 9.2M | 5.46 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated